Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,052
Closed -$716K 133
2020
Q3
$716K Buy
9,052
+3,612
+66% +$283K 0.24% 104
2020
Q2
$401K Sell
5,440
-358
-6% -$27K 0.15% 123
2020
Q1
$426K Sell
5,798
-2,581
-31% -$203K 0.2% 105
2019
Q4
$727K Buy
8,379
+925
+12% +$76K 0.33% 98
2019
Q3
$599K Buy
7,454
+642
+9% +$51.5K 0.28% 104
2019
Q2
$545K Buy
6,812
+345
+5% +$26.4K 0.23% 108
2019
Q1
$513K Sell
6,467
-273
-4% -$20.4K 0.23% 113
2018
Q4
$491K Buy
6,740
+524
+8% +$37K 0.25% 103
2018
Q3
$421K Sell
6,216
-15
-0.2% -$956 0.16% 132
2018
Q2
$361K Buy
6,231
+677
+12% +$38.2K 0.16% 121
2018
Q1
$289K Buy
5,554
+1,076
+24% +$58.1K 0.13% 121
2017
Q4
$240K Buy
4,478
+900
+25% +$49.9K 0.12% 111
2017
Q3
$219K Sell
3,578
-227
-6% -$13.8K 0.1% 106
2017
Q2
$233K Buy
+3,805
New +$232K 0.1% 99

Other funds holding MRK

Cedar Capital's MRK Position: Q4 2020 in Review

Cedar Capital sold out of Merck (MRK) in Q4 2020, closing a stake of 9,052 shares — an estimated $716K sold.

Cedar Capital first reported a position in MRK in Q2 2017 and held it in 14 quarters. The position peaked at $727K in Q4 2019. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Cedar Capital reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 9,052 Merck shares in Q4 2020, an estimated $716K.
  • Cedar Capital first reported a position in Merck in Q2 2017 and held it in 14 quarters.
  • Cedar Capital's Merck position peaked at $727K in Q4 2019.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.